Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions

Neuropsychopharmacology

Volumn 30, Issue 6, 2005, Pages 1121-1127

  Addy, Nii A ^a   Pocivavsek, Ana ^a   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clozapine; Fimbria fornix; Hippocampus; Memory; Nicotine; Radial arm maze

Indexed keywords

CLOZAPINE; NICOTINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FORNIX; BRAIN INJURY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; FEMALE; FIMBRIA; HIPPOCAMPUS; KNIFE CUT; MAZE TEST; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; SEPTUM PELLUCIDUM; WORKING MEMORY;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; FORNIX (BRAIN); HIPPOCAMPUS; MAZE LEARNING; MEMORY, SHORT-TERM; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 19344363945     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300669     Document Type: Article

References (62)

1. Addy N, Levin ED (2002). Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats. Neuropsychopharmacology 27: 534-541.
2. Arthur D, Levin ED (2002). Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response. Psychopharmacology 160: 140-145.
3. Balse E, Lazarus C, Kelche C, Jeltsch H, Jackisch R, Cassel J (1999). Intrahippocampal grafts containing cholinergic and serotonergic fetal neurons ameliorate spatial reference but not working memory in rats with fimbria-fornix/cingular bundle lesions. Brain Res Bull 49: 263-272.
4. Bancroft A, Levin ED (2000). Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory. Neuropharmacology 39: 2770-2778.
5. Bernaerts P, Tirelli E (2003). Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice. Behav Brain Res 142: 41-52.
6. Bettany JH, Levin ED (2001). Ventral hippocampal alpha7 nicotinic receptors and chronic nicotine effects on memory. Pharmacol Biochem Behav 70: 467-474.
7. Buhot M, Patra S, Naili S (1995). Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat. Eur J Pharmacol 285: 221-228.
8. Buhot MC (1997). Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 7: 243-254.
9. Burns MJ (2001). The pharmacology and toxicology of atypical antipsychotic agents. J Toxicol Clin Toxicol 39: 1-14.
10. Carli M, Bonalumi P, Samanin R (1997). WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. Brain Res 774: 167-174.
11. Cassaday H, Norman C, Shilliam C, Vincent C, Marsden C (2003). Intraventricular 5,7-dihydroxytryptamine lesions disrupt acquisition of working memory task rules but not performance once learned. Progr Neuro-Psychopharmacol Biol Psychiatry 27: 147-156.
12. Chou Y, Halldin C, Farde L (2003). Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study. Psychopharmacology 166: 234-240.
13. Cornblatt BA, Keilp JG (1994). Impaired attention, genetics, and the pathophysiology of schizophrenia. Schiz Bull 20: 31-46.
14. Felix R, Levin ED (1997). Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 81: 1009-1017.
15. Gallhofer B, Bauer U, Lis S, Krieger S, Gruppe H (1996). Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol 6: S13-S20.
16. Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D et al (1993). The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 162: 43-48.
17. Goldberg TE, Weinberger DR (1996). Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies. J Clin Psychiatry 57(Suppl 9): 62-65.
18. Goldman-Rakic P (1996). Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA 93: 13473-13480.
19. Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY (1993). Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 34: 702-712.
20. Herran A, de Santiago A, Sandoya M, Fernandez MJ, Diez-Manrique JF, Vazquez-Barquero JL (2000). Determinants of smoking behaviour in outpatients with schizophrenia. Schizophr Res 41: 373-381.
21. Hironaka N, Tanaka K, Izaki Y, Hori K, Nomura M (2001). Memory-related acetycholine efflux from rat prefrontal cortex and hippocampus: a microdialysis study. Brain Res 901: 143-150.
22. Hoff AL, Faustman WO, Wieneke M, Espinoza S, Costa M, Wolkowitz O et al (1996). The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients. Neuropsychopharmacology 15: 361-369.
23. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA (1986). Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143: 993-997.
24. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY (2002). Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26: 325-339.
25. Ikegami S (1994). Behavioral impairment in radial-arm maze learning and acetylcholine content of the hippocampus and cerebral cortex in aged mice. Behav Brain Res 65: 103-111.
26. Jarrard LE (1993). On the role of the hippocampus in learning and memory in the rat. Behav Neural Biol 60: 9-26.
27. Kim J, Levin E (1996). Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats. Brain Res 725: 231-240.
28. Laroche S, Davis S, Jay T (2000). Plasticity at hippocampal to prefrontal cortex synapses: dual roles in working memory and consolidation. Hippocampus 10: 438-446.
29. Lee MA, Jayathilake K, Meltzer HY (1999). A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophr Res 37: 1-11.
30. Levin ED (1997). Chronic haloperidol administration does not block acute nicotine-induced improvements in radial-arm maze performance in the rat. Pharmacol Biochem Behav 58: 899-902.
31. Levin ED, Bettegowda C, Blosser J, Gordon J (1999a). AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10: 675-680.
32. Levin ED, Bradley A, Addy N, Sigurani N (2002). Hippocampal α7 and α4β2 nicotinic receptors and working memory. Neuroscience 109: 757-765.
33. Levin ED, Christopher NC, Briggs SJ, Rose JE (1993). Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Cogn Brain Res 1: 137-143.
34. Levin ED, Christopher NC, Weaver T, Moore J, Brucato F (1999b). Ventral hippocampal ibotenic acid lesions block chronic nicotine-induced spatial working memory improvement in rats. Cogn Brain Res 7: 405-410.
35. Levin ED, Simon BB (1998). Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138: 217-230.
36. Levin ED, Wilson W, Rose JE, McEvoy J (1996). Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15: 429-436.
37. Lieben C, Oorsouw K, Deutz N, Blokland A (2004). Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat. Behav Brain Res 151: 53-64.
38. Manschreck TC, Redmond DA, Candela SF, Maher BA (1999). Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia. J Neuropsychiatr Clin Neurosci 11: 481-489.
39. Matsubara S, Matsubara R, Kusumi I, Koyama T, Yamashita I (1993). Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J Pharmacol Exp Therap 265: 498-508.
40. McGurk S, Levin ED, Butcher LL (1988). Cholinergic-dopaminergic interactions in radial-arm maze performance. Behav Neural Biol 49: 234-239.
41. McGurk SR (1999). The effects of clozapine on cognitive functioning in schizophrenia. J Clin Psychiatry 60(Suppl 12): 24-29.
42. Meltzer HY, McGurk SR (1999). The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25: 233-255.
43. Michal P, Lysikova M, El-Fakahany E, Stanislav T (1999). Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors. Eur J Pharmacol 376: 119-125.
44. Ohno M, Watanabe S (1996). Blockade of 5-HT1A receptors compensates loss of hippocampal cholinergic neurotransmission involved in working memory of rats. Brain Res 736: 180-188.
45. Ohno M, Yamamoto T, Watanabe S (1994). Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats. Brain Res 650: 260-266.
46. Pache D, Fernandez-Perez S, Sewell R (2003). Buspirone differentially modifies short-term memory function in a combined delayed matching/non-matching to position task. Eur J Pharmacol 477: 205-211.
47. Parada MA, Hernandez L, Puig De Parada M, Rada P, Murzi E (1997). Selective action of acute systemic clozapine on acetycholine release in the rat prefrontal cortex by reference to the nucleus accumbens and striatum. J Pharamacol Exp Therap 281: 582-588.
48. Park S, Coull J, McShane R, Young A, Sahakian B, Robbins T et al (1994). Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33: 575-588.
49. Porter R, Lunn B, O'Brien J (2003). Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly. Psychol Med 33: 41-49.
50. Rezvani A, Caldwell D, Levin E (2004). Nicotine-antipsychotic drug interactions and attentional performance. Eur J Pharmacol 486: 175-182.
51. Sharma T, Mockler D (1998). The cognitive efficacy of atypical antipsychotics in schizophrenia. J Clin Psychopharmacol 18: 12S-19S.
52. Shirazi-Southall S, Rodriguez DA, Nomikos GG (2002). Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26: 583-894.
53. Skarsfeldt T (1996). Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics. Psychopharmacology 124: 126-133.
54. Stip E (1996). Memory impairment in schizophrenia: perspectives from psychopathology and pharmacotherapy. Canad J Psychiatry 41: S27-S34.
55. Tollefson GD (1996). Cognitive function in schizophrenic patients. J Clin Psychiatry 57(Suppl 11): 31-39.
56. Tsukada H, Nishiyama S, Fukumoto D, Ohba H, Sato K, Kakiuchi T (2004). Effects of acute acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: functional imaging of the conscious monkey brain using animal PET in combination with microdialysis. Synapse 52: 1-10.
57. Umegaki H, Munoz J, Meyer R, Spangler E, Yoshimura J, Ikari H et al (2001). Involvement of dopamine D(2) receptors in complex maze learning and acetylcholine release in ventral hippocampus of rats. Neuroscience 103: 27-33.
58. Warburton E, Harrison A, Robbins T, Everitt B (1997). Contrasting effects of systemic and intracerebral infusions of the 5-HT1A receptor agonist 8-OH-DPAT on spatial short-term working memory in rats. Behav Brain Res 84: 247-258.
59. Weinberger DR, Gallhofer B (1997). Cognitive function in schizophrenia. Int Clin Psychopharmacol 12(Suppl 4): S29-S36.
60. Wilkerson A, Levin ED (1999). Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats. Neuroscience 89: 743-749.
61. Wonnacott S, Irons J, Rapier C, Thorne B, Lunt GG (1989). Presynaptic modulation of transmitter release by nicotinic receptors. In: Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds). Progress in Brain Research. Elsevier Science Publishers B.V.: Amsterdam. pp 157-163.
62. Zhang K, Grady C, Tsapakis E, Andersen S, Tarazi F, Baldessarini R (2004). Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology 29: 1648-1655.